Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZ) EBITDA: 2021-2025

Historic EBITDA for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to -$57.4 million.

  • Core Scientific's EBITDA fell 39.32% to -$57.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$166.1 million, marking a year-over-year decrease of 777.33%. This contributed to the annual value of -$19.2 million for FY2024, which is 314.22% down from last year.
  • Latest data reveals that Core Scientific reported EBITDA of -$57.4 million as of Q3 2025, which was down 118.48% from -$26.3 million recorded in Q2 2025.
  • In the past 5 years, Core Scientific's EBITDA registered a high of $102.2 million during Q4 2021, and its lowest value of -$1.0 billion during Q2 2022.
  • For the 3-year period, Core Scientific's EBITDA averaged around -$12.4 million, with its median value being -$12.0 million (2023).
  • As far as peak fluctuations go, Core Scientific's EBITDA slumped by 8,489.92% in 2022, and later surged by 626.48% in 2024.
  • Core Scientific's EBITDA (Quarterly) stood at $102.2 million in 2021, then slumped by 722.64% to -$636.1 million in 2022, then surged by 100.62% to $3.9 million in 2023, then slumped by 1,111.26% to -$39.8 million in 2024, then plummeted by 39.32% to -$57.4 million in 2025.
  • Its last three reported values are -$57.4 million in Q3 2025, -$26.3 million for Q2 2025, and -$42.6 million during Q1 2025.